lifestyle.thedishh.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Larimar Therapeutics
Larimar Therapeutics to Participate in Upcoming Investor Conferences in March
March 4, 2026
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering
February 25, 2026
Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering
February 25, 2026
Larimar Therapeutics Announces FDA Breakthrough Therapy Designation for Nomlabofusp in FA and Reiterates Planned BLA Submission in June 2026
February 24, 2026